Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
about
Malaria parasite pre-erythrocytic stage infection: gliding and hidingEuropean Vaccine Initiative: lessons from developing malaria vaccinesNovel approaches to identify protective malaria vaccine candidatesWhat do human parasites do with a chloroplast anyway?Acquired immunity to malariaExpanding the antimalarial toolkit: Targeting host-parasite interactionsProspects for immunotherapy and vaccines against CryptosporidiumCD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infectionBroadening the horizons for yellow feverMalaria: progress, perils, and prospects for eradicationCrystal Structure of Soluble Domain of Malaria Sporozoite Protein UIS3 in Complex with LipidProtein targeting to the parasitophorous vacuole membrane of Plasmodium falciparumIdentification of an AP2-family protein that is critical for malaria liver stage developmentA sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage developmentProtective immunity to liver-stage malariaEvidence-based annotation of the malaria parasite's genome using comparative expression profilingA systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquitoTranscriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoeliiLive vaccination tactics: possible approaches for controlling visceral leishmaniasisComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensIdentification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profilingInteraction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteinsFunctional profiles of orphan membrane transporters in the life cycle of the malaria parasiteLiver-specific protein 2: a Plasmodium protein exported to the hepatocyte cytoplasm and required for merozoite formationPreerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by designInactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoitesA Novel and Conserved Plasmodium Sporozoite Membrane Protein SPELD is Required for Maturation of Exo-erythrocytic FormsControlling malaria: competition, seasonality and 'slingshotting' transgenic mosquitoes into natural populations.CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.A rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasites.Shedding of host autophagic proteins from the parasitophorous vacuolar membrane of Plasmodium berghei.Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilitiesSerial Analysis of Gene Expression in Plasmodium berghei salivary gland sporozoites.Sterile protection against malaria is independent of immune responses to the circumsporozoite protein.Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivityConserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoitesMalaria vaccines: where next?A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.
P2860
Q56736942-F968D671-7579-4832-A791-5996254201FDQ59757964-9169A493-144E-4B69-854F-6559856BEDF5Q59890392-3504FF94-0F5D-4B98-ABE9-52E36E044815Q59921866-967B58BF-F975-408B-B5FB-033394FC0CB0Q59921866-D59C616F-A9A3-463D-9289-A51D67489E40Q59973805-B60D2DB4-D6CE-402B-95B1-2CF58A744416Q60002105-AAA29CB1-9B3A-4282-8BDD-D55988D506BBQ60002517-92EC94DE-B9A2-4578-B5FC-CBA44683B4BFQ60016122-B7A73D40-853C-4085-B8F0-4344BF973F34
P1343
Q21032491-D8A1279F-C077-410E-9746-E76084086C18Q21032652-9F94F276-384F-4B25-8134-0B559AFA2F7DQ21131082-EB936DF6-6067-4664-BAD6-9896A052E7AFQ21145764-BDD2DDB0-5171-4DF5-8A33-3D13BA1004CEQ24651173-32DF0C39-B660-4430-B1A4-B832CE89791DQ26772866-A734519B-F502-4748-AFF7-E9F3751CB645Q27005885-DACCE9BF-CECD-42F2-9D10-3CCD600C8F7EQ27323125-7560C62B-3475-4971-87ED-3AA3DADB3E26Q27485206-9A445EDD-26EF-4F29-9384-98FF502F77E9Q27485634-B1B1E93E-F5BE-484C-8A67-A87DD46697DCQ27650935-BA8347FC-432E-434A-AAD3-5220313EA4F1Q27972621-D33EAC7F-0E17-4DD3-B82F-E362ADB2EEDFQ27973490-55A84737-47CF-4E56-BC5E-17730A77F145Q27973897-BC476F61-7C55-4BE3-9A38-585F0310D40EQ28068626-0947C82B-6C70-4A45-BAF5-F0206E089534Q28472095-E9074337-C6E4-4FAC-97FD-5B9D35FDD053Q28473572-714FFF23-23BC-42E3-AF72-84F7FEE40201Q28473729-CDFE74AC-6831-4BC8-9C3F-2287127FCD39Q28542081-AF2BF4E8-1EAC-4C35-915D-402E95F8F6DAQ28551311-A2D3B351-C9FD-45CA-8B66-1AF18D28B481Q28704543-0CD9115B-6FD2-440B-ADC8-089BF9240C57Q28756674-5D3A258C-A94B-4C69-9F45-ECB85F5D6A04Q30042996-B9750D13-A82D-4E40-9BD7-4295D2C8F400Q30043150-73F2A950-9F25-467A-AEE0-1B7DF888D6FBQ30043830-063EEFB8-51C8-45DF-8AED-130BC26A9573Q30043892-0C67D2D9-9F20-4E17-91CB-EFECB33CF196Q30044206-39D9E5D2-CE6C-49B0-BEAB-ADA5060C261BQ30420219-8F3496D4-B5FF-4D7B-B2EC-6DCAA171AA21Q30555356-86DA669D-4629-4BF0-B95B-6014F93411C1Q30576767-29F777F8-A4D8-4F1D-BFCE-DFDB7D6CE040Q30852064-22AC1956-124A-454C-80F6-98ABFD8F7CACQ31152863-A8D40DC3-EF15-451A-90A7-480E3D93B4F6Q33311376-3F0142B5-10BD-47D7-8317-A1905BD19C05Q33312392-F97503A6-588A-493A-B032-F462B041FE9BQ33358681-D5A7FDB1-813B-486B-949F-3CFCCE827143Q33380159-8E68B0D2-DDD0-4CCE-9169-D51B2C2F971CQ33381649-12E4CEB9-8536-44A3-97B9-58503736552FQ33408831-6E90C589-25AE-4E76-ACC7-EB04AF855305Q33513966-8F2CAB16-C953-4CFC-BC6C-90D8374824B4Q33515022-D181E7D0-75C1-42AE-B760-EE27E0D0CFCD
P2860
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@en
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@nl
type
label
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@en
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@nl
prefLabel
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@en
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@nl
P2860
P921
P356
P1433
P1476
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
@en
P2093
Ann-Kristin Mueller
Mehdi Labaied
P2507
P2860
P2888
P304
P356
10.1038/NATURE03188
P407
P577
2004-12-05T00:00:00Z
P5875
P6179
1040405574